Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Telix Pharmaceuticals
Biotech
Telix pays $45M for ImaginAb's preclinical antibodies, facility
Along with the $10 million cash payment and a $35 million equity investment, ImaginAb could be in line for $185 million in milestone payments.
James Waldron
Jan 13, 2025 7:50am
Cell-focused Sana scoops first CSO—Chutes & Ladders
Aug 30, 2024 8:30am
Radiopharma biotech Telix drops Nasdaq IPO plans at last minute
Jun 14, 2024 5:37am
Radiopharma-focused Telix targets $200M IPO
Jun 5, 2024 10:57am
Telix offers $33M to acquire Qsam and phase 1 bone cancer drug
Nov 14, 2023 8:20am
Agios replaces CEO after recent FDA nod—Chutes & Ladders
Jul 15, 2022 9:30am
